Myeloablative Fractionated Busulfan, Fludarabine, Cladribine, Thiotepa and Venetoclax (cladillac) Conditioning Regimen for Very High-Risk AML/MDS: A Phase 2 TrialUday Popat,Roland L. Bassett,Amin M. Alousi,Gheath Alatrash, Yosra M. Aljawai,Qaiser Bashir,George Chen,Warren B. Fingrut,Chitra Hosing,Jin S. Im,Partow Kebriaei,David Marin,Yago Nieto,Amanda L. Olson,Betul Oran,Muzaffar H. Qazilbash,Jeremy Ramdial,Neeraj Y. Saini,Portia Smallbone,Samer A. Srour,Benigno C. Valdez,Richard E. Champlin,Borje S. Andersson,Elizabeth J. ShpallBLOOD(2024)引用 0|浏览0AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要